FR2396756A1 - Nouvelles benzylidene-2-benzofurannones-3, leur obtention et leur application a titre de medicaments - Google Patents

Nouvelles benzylidene-2-benzofurannones-3, leur obtention et leur application a titre de medicaments

Info

Publication number
FR2396756A1
FR2396756A1 FR7720869A FR7720869A FR2396756A1 FR 2396756 A1 FR2396756 A1 FR 2396756A1 FR 7720869 A FR7720869 A FR 7720869A FR 7720869 A FR7720869 A FR 7720869A FR 2396756 A1 FR2396756 A1 FR 2396756A1
Authority
FR
France
Prior art keywords
benzofurannones
obtaining
application
medicinal products
benzylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7720869A
Other languages
English (en)
Inventor
Henri Orzalesi
Jean Castel
Roland Darmanaden
Olivier Fl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR7720869A priority Critical patent/FR2396756A1/fr
Priority to JP8246678A priority patent/JPS5444659A/ja
Priority to DE19782829619 priority patent/DE2829619A1/de
Priority to GB787829032A priority patent/GB2001631A/en
Publication of FR2396756A1 publication Critical patent/FR2396756A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)

Abstract

Nouveaux produits et leur obtention. Il s'agit de benzylidène-2 benzofurannones-2 répondant à la formule :
FR7720869A 1977-07-06 1977-07-06 Nouvelles benzylidene-2-benzofurannones-3, leur obtention et leur application a titre de medicaments Withdrawn FR2396756A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR7720869A FR2396756A1 (fr) 1977-07-06 1977-07-06 Nouvelles benzylidene-2-benzofurannones-3, leur obtention et leur application a titre de medicaments
JP8246678A JPS5444659A (en) 1977-07-06 1978-07-06 Novel medicine based on 22benzylidenee33 benzofuranon*novel 22benzylidinee33benzofuranon and their manufacture
DE19782829619 DE2829619A1 (de) 1977-07-06 1978-07-06 Arzneimittel, enthaltend benzyliden- 2-benzofurane
GB787829032A GB2001631A (en) 1977-07-06 1978-07-06 Physiologically-active benzofuranone derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7720869A FR2396756A1 (fr) 1977-07-06 1977-07-06 Nouvelles benzylidene-2-benzofurannones-3, leur obtention et leur application a titre de medicaments

Publications (1)

Publication Number Publication Date
FR2396756A1 true FR2396756A1 (fr) 1979-02-02

Family

ID=9193073

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720869A Withdrawn FR2396756A1 (fr) 1977-07-06 1977-07-06 Nouvelles benzylidene-2-benzofurannones-3, leur obtention et leur application a titre de medicaments

Country Status (4)

Country Link
JP (1) JPS5444659A (fr)
DE (1) DE2829619A1 (fr)
FR (1) FR2396756A1 (fr)
GB (1) GB2001631A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2436144A1 (fr) * 1978-09-13 1980-04-11 Lilly Industries Ltd Nouveaux derives d'aurones, leur procede de preparation et leur utilisation comme produits pharmaceutiques

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG14105A (en) * 1978-09-13 1983-03-31 Lilly Industries Ltd A process for the preparation of aurone derivatives
ZA863425B (en) * 1985-05-08 1988-01-27 Du Pont 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
US5026759A (en) * 1985-05-08 1991-06-25 Du Pont Merck Pharmaceutical 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
JP2006290886A (ja) * 2005-04-06 2006-10-26 Engelhard Lyon Sa 少なくとも１種のアウロンを適用することによる美容的脱色素沈着ケア方法
CN109369583A (zh) * 2018-12-07 2019-02-22 广东药科大学 一类PPARγ/δ双重激动剂、其制备方法及其作为药物的用途

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2436144A1 (fr) * 1978-09-13 1980-04-11 Lilly Industries Ltd Nouveaux derives d'aurones, leur procede de preparation et leur utilisation comme produits pharmaceutiques

Also Published As

Publication number Publication date
GB2001631A (en) 1979-02-07
DE2829619A1 (de) 1979-01-25
JPS5444659A (en) 1979-04-09

Similar Documents

Publication Publication Date Title
FR2372810A1 (fr) Nouvelles aminoalcoylimidazolidinones, procedes pour leur preparation et leur utilisation en tant que medicaments
FR2390420A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
FR2377377A1 (fr) Amides derives du trimethoxy-3,4,5 benzene et leur application comme medicaments
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2387954A1 (fr) Derives de mercaptoalkylsulfonylproline et composes apparentes, et leur utilisation comme medicaments
FR2392978A2 (fr) Naphtalimides substitues utilisables comme medicaments
FR2391209A1 (fr) Aminoalkyl thiophenes, utiles comme medicaments, leur preparation et compositions en contenant
FR2383922A1 (fr) Nouvelles 4-acylamino-phenyl-ethanolamines, procede pour leur preparation et leur utilisation en tant que medicaments
FR2394534A1 (fr) Nouveaux 1-aryloxy-2-hydroxy-3-alcoyleneaminopropanes, procedes pour leur preparation et medicaments les renfermant
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
FR2387971A1 (fr) Nouvelles trimethoxy cinnamoyles piperazines, leur procede de preparation et leur application en therapeutique
FR2363556A1 (fr) Nouvelles phenylethylamines, leur preparation et leur utilisation en tant que medicaments
FR2392991A1 (fr) Nouvelles 5,11-dihydro-6h-pyrido(2,3-b) (1,4) benzodiazepin-6-ones substituees en position 11, procedes pour leur preparation et medicaments renfermant ces composes
FR2361398A1 (fr) Nouvelles 6-aryl-4h-s-triazolo-(3,4c)-thieno(2,3e)-1,4-diazepines, leur preparation et leur utilisation en tant que medicaments
LU79356A1 (fr) Preparation d'interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
FR2388795A1 (fr) Nouveaux n-(1-(3-benzoylpropyl)-4-piperidyl)-sulfamides, procedes pour leur preparation et medicaments les renfermant
FR2390454A1 (fr) 17-alkylthio (et arylthio)-1', 2', 3', 4'-tetrahydroandrosteno(16 a, 17 a-b)naphtalenes et derives, et leur utilisation comme medicaments
BE854072A (fr) Nouvelles aminopiperidines, leur preparation et leur emploi comme medicament
FR2378014A1 (fr) Nouveaux derives aminoalcoxyphenyles, leur preparation et leur utilisation en tant que medicaments
FR2445329A1 (fr) Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament
FR2379533A1 (fr) Tetrazolylcarbamoylquinoleines utilisables comme medicaments et leur preparation
FR2427335A1 (fr) Derives du 5-nitro-imidazole, leur preparation et leurs utilisations comme medicaments antiprotozoaires
FR2393793A1 (fr) Derives de dichloro-3,3 azetidinones-2 a substituants basiques, leur procede de preparation et leur utilisation comme medicaments anti-inflammatoires
FR2396756A1 (fr) Nouvelles benzylidene-2-benzofurannones-3, leur obtention et leur application a titre de medicaments
FR2370745A1 (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse